Page last updated: 2024-10-21

5,7-dichlorokynurenic acid and Constriction, Pathologic

5,7-dichlorokynurenic acid has been researched along with Constriction, Pathologic in 1 studies

5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site

Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
"The importance of this mechanism in neuropathic pain remains unclear."1.33Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms. ( Chizh, BA; Christoph, T; Englberger, W; Reissmüller, E; Schiene, K, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christoph, T1
Reissmüller, E1
Schiene, K1
Englberger, W1
Chizh, BA1

Other Studies

1 other study available for 5,7-dichlorokynurenic acid and Constriction, Pathologic

ArticleYear
Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
    Brain research, 2005, Jun-28, Volume: 1048, Issue:1-2

    Topics: Action Potentials; Animals; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relation

2005